Harrow Health Inc (NASDAQ:HROW)
| 14.35 Delayed Data As of Sep 27 |  +0.34 / +2.42%Today’s Change | 7.57 Today|||52-Week Range 28.25 | -2.78% Year-to-Date |
Latest HROW News | Press Releases
No recent news for Harrow Health Inc.
Today’s Trading
| Previous close | 14.03 |
| Today’s open | 14.05 |
| Day’s range | 13.96 - 14.60 |
| Volume | 332,840 |
| Average volume (3 months) | 552,474 |
| Market cap | $493.7M |
Data as of 3:59pm ET, 09/27/2023
Growth & Valuation
| Earnings growth (last year) | +25.72% |
| Earnings growth (this year) | +15.95% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | +22.24% |
| P/E ratio | NM |
| Price/Sales | 4.58 |
| Price/Book | 15.25 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SVRASavara Inc | +0.02 | +0.54% |
| PAHCPhibro Animal Health... | -0.25 | -1.92% |
| EOLSEvolus Inc | +0.22 | +2.48% |
| ---- |
Data as of 3:59pm ET, 09/27/2023
Financials
| Next reporting date | November 13, 2023 |
| EPS forecast (this quarter) | $0.08 |
| Annual revenue (last year) | $88.6M |
| Annual profit (last year) | -$14.1M |
| Net profit margin | -15.90% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Nashville, Tennessee |
Forecasts
